A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron
Withdrawn before enrolling · Phase 4
Conditions studied: Iron Deficiency
In brief
This is a pilot study designed to compare the tolerance of ionic iron (ferrous sulphate) with heme iron polypeptide. Subjects will take one week of one product followed by a week with no product followed by a week with the other product. Subjects will complete a daily diary to assess side effects. Hypothesis: Heme iron polypeptide is associated with fewer gastrointestinal side effects than ionic iron.
Key facts
- Study ID
- NCT01865175
- Run by
- Milton S. Hershey Medical Center
- People needed
- 0
- Starts
- 2016-01-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2016-09-14
Who can join
Age: 7 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- able to fill out daily diary
You may not qualify if…
- known iron overload
- sensitivity to either product used
Where it is running
- Hershey Medical Center — Hershey, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.